NCT04745624 (VASCADE) is a clinical trial in Common Femoral Artery Stenosis, sponsored by Yale University.

Who is sponsoring NCT04745624?

NCT04745624 is sponsored by Yale University.

What condition does NCT04745624 study?

NCT04745624 studies Common Femoral Artery Stenosis.

Is NCT04745624 still recruiting?

NCT04745624 is currently completed. Last updated 3 February 2022.

Last reviewed 2022-02-03 · How we verify

NCT04745624: VASCADE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease

Completed Last updated 3 February 2022

What this trial tests

trial in Common Femoral Artery Stenosis in 200 participants. Completed in 1 December 2021.

Timeline

20 August 2020

Primary endpoint
1 December 2021

1 December 2021

Quick facts

Lead sponsor	Yale University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	20 August 2020
Primary completion	1 December 2021
Estimated completion	1 December 2021
Sites	1 location across United States

Conditions studied

Common Femoral Artery Stenosis — all drugs for Common Femoral Artery Stenosis →

Sponsor

Yale University

Who can join

Adults 18 to 100, any sex, with Common Femoral Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the patient characteristics and outcomes associated with the real-world use of manual compression vs. vascular closure devices (VCDs) after common femoral artery (CFA) percutaneous access for coronary and endovascular interventions. An institutional procedural database, based on electronic medical record information will be abstracted to collect this information.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Common Femoral Artery Stenosis

Currently open trials in the same condition.

NCT06829914 — Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safet · NA · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04745624 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 3 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04745624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing